Repligen Free Cash Flow (FCF) History (RGEN)
Repligen reported $93.9M in free cash flow for fiscal 2025, a decrease of 37.28% from the previous fiscal year, with a free cash flow margin of 12.72%.
View full Repligen company overviewRepligen free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | $93.9M | −$55.8M | −37.28% | +12.72% |
| 2024 | 2024-12-31 | $149.7M | $72.0M | +92.70% | +23.60% |
| 2023 | 2023-12-31 | $77.7M | −$9.6M | −10.95% | +12.29% |
| 2022 | 2022-12-31 | $87.2M | $35.3M | +68.02% | +10.89% |
| 2021 | 2021-12-31 | $51.9M | $11.8M | +29.27% | +7.74% |
| 2020 | 2020-12-31 | $40.2M | −$8.5M | −17.54% | +10.97% |
| 2019 | 2019-12-31 | $48.7M | $26.6M | +120.07% | +18.03% |
| 2018 | 2018-12-31 | $22.1M | $10.1M | +84.50% | +11.41% |
| 2017 | 2017-12-31 | $12.0M | $8.8M | +275.38% | +8.49% |
| 2016 | 2016-12-31 | $3.2M | −$9.2M | −74.28% | +3.06% |
| 2015 | 2015-12-31 | $12.4M | −$374,000 | −2.92% | +14.87% |
| 2014 | 2014-12-31 | $12.8M | −$8.5M | −39.90% | +20.14% |
| 2013 | 2013-12-31 | $21.3M | $9.1M | +74.89% | +31.24% |
| 2012 | 2012-12-31 | $12.2M | $10.4M | +601.67% | +19.55% |
| 2011 · Dec 31 | 2011-12-31 | $1.7M | — | — | +7.40% |
| 2011 · Mar 31 | 2011-03-31 | $2.7M | $5.8M | — | +9.92% |
| 2010 | 2010-03-31 | −$3.0M | — | — | −14.52% |
Repligen quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $27.4M | $5.9M | +27.54% | +13.44% |
| Q1 2026 | 2026-03-31 | $23.6M | $12.1M | +106.13% | +12.14% |
| Q4 2025 | 2025-12-31 | $17.6M | — | — | +8.87% |
| Q3 2025 | 2025-09-30 | $43.4M | $1.1M | +2.50% | +22.99% |
| Q2 2025 | 2025-06-30 | $21.5M | −$15.9M | −42.46% | +11.79% |
| Q1 2025 | 2025-03-31 | $11.4M | −$24.9M | −68.53% | +6.76% |
| Q3 2024 · Sep 30 | 2024-09-30 | $42.3M | $11.5M | +37.26% | +27.34% |
| Q2 2024 | 2024-06-30 | $37.4M | $11.2M | +42.53% | +23.53% |
| Q1 2024 | 2024-03-31 | $36.4M | $33.7M | +1274.74% | +23.74% |
| Q4 2023 | 2023-12-31 | $18.0M | −$23.5M | −56.61% | +10.79% |
| Q3 2023 | 2023-09-30 | $30.8M | $1.3M | +4.37% | +21.85% |
| Q2 2023 | 2023-06-30 | $26.2M | $5.9M | +28.89% | +16.48% |
| Q1 2023 | 2023-03-31 | $2.6M | $6.7M | — | +1.60% |
| Q4 2022 | 2022-12-31 | $41.4M | $23.9M | +136.79% | +22.19% |
| Q3 2022 | 2022-09-30 | $29.6M | $18.0M | +154.94% | +14.72% |
| Q2 2022 | 2022-06-30 | $20.3M | −$808,000 | −3.82% | +9.80% |
| Q1 2022 | 2022-03-31 | −$4.1M | −$5.8M | — | −1.98% |
| Q4 2021 | 2021-12-31 | $17.5M | $14.0M | +402.44% | +9.38% |
| Q3 2021 | 2021-09-30 | $11.6M | −$6.1M | −34.56% | +6.50% |
| Q2 2021 | 2021-06-30 | $21.2M | $7.6M | +55.91% | +12.98% |
| Q1 2021 | 2021-03-31 | $1.7M | −$3.7M | −68.95% | +1.17% |
| Q4 2020 | 2020-12-31 | $3.5M | −$7.1M | −67.09% | +3.21% |
| Q3 2020 | 2020-09-30 | $17.7M | $1.3M | +8.01% | +18.83% |
| Q2 2020 | 2020-06-30 | $13.6M | −$460,000 | −3.28% | +15.52% |
| Q1 2020 | 2020-03-31 | $5.4M | −$2.3M | −29.82% | +7.10% |
| Q4 2019 | 2019-12-31 | $10.6M | $8.3M | +362.54% | +15.23% |
| Q3 2019 | 2019-09-30 | $16.4M | −$325,000 | −1.94% | +23.61% |
| Q2 2019 | 2019-06-30 | $14.0M | $10.9M | +350.40% | +19.85% |
| Q1 2019 | 2019-03-31 | $7.7M | $7.7M | +96150.00% | +12.70% |
| Q4 2018 | 2018-12-31 | $2.3M | −$11.2M | −82.99% | +4.40% |
| Q3 2018 | 2018-09-30 | $16.7M | $19.5M | — | +33.77% |
| Q2 2018 | 2018-06-30 | $3.1M | $1.7M | +117.38% | +6.53% |
| Q1 2018 | 2018-03-31 | $8,000 | $156,000 | — | +0.02% |
| Q4 2017 | 2017-12-31 | $13.4M | $12.4M | +1132.81% | +32.32% |
| Q3 2017 | 2017-09-30 | −$2.7M | $504,000 | — | −7.48% |
| Q2 2017 | 2017-06-30 | $1.4M | −$8.2M | −85.06% | +4.42% |
| Q1 2017 | 2017-03-31 | −$148,000 | $4.1M | — | −0.48% |
| Q4 2016 | 2016-12-31 | $1.1M | −$1.7M | −60.74% | +4.26% |
| Q3 2016 | 2016-09-30 | −$3.2M | −$9.5M | — | −13.14% |
| Q2 2016 | 2016-06-30 | $9.6M | $2.6M | +37.91% | +32.87% |
| Q1 2016 | 2016-03-31 | −$4.2M | −$665,000 | — | −16.90% |
| Q4 2015 | 2015-12-31 | $2.8M | $3.7M | — | +12.96% |
| Q3 2015 | 2015-09-30 | $6.3M | $1.7M | +36.67% | +31.64% |
| Q2 2015 | 2015-06-30 | $7.0M | $5.3M | +310.39% | +32.40% |
| Q1 2015 | 2015-03-31 | −$3.6M | −$11.0M | — | −17.18% |
| Q4 2014 | 2014-12-31 | −$885,000 | −$7.4M | — | −5.40% |
| Q3 2014 | 2014-09-30 | $4.6M | $1.1M | +29.91% | +30.03% |
| Q2 2014 | 2014-06-30 | $1.7M | −$6.3M | −78.86% | +10.89% |
| Q1 2014 | 2014-03-31 | $7.4M | $4.1M | +126.18% | +45.34% |
| Q4 2013 | 2013-12-31 | $6.5M | −$312,803 | −4.61% | +42.11% |
| Q3 2013 | 2013-09-30 | $3.5M | $1.4M | +63.51% | +18.76% |
| Q2 2013 | 2013-06-30 | $8.0M | $6.4M | +386.15% | +45.76% |
| Q1 2013 | 2013-03-31 | $3.3M | $1.7M | +107.51% | +19.89% |
| Q4 2012 | 2012-12-31 | $6.8M | $3.4M | +99.79% | +36.09% |
| Q3 2012 | 2012-09-30 | $2.2M | $2.2M | — | +14.30% |
| Q2 2012 · Jun 30 | 2012-06-30 | $1.6M | $4.5M | — | +10.62% |
| Q1 2012 · Mar 31 | 2012-03-31 | $1.6M | $339,684 | +27.45% | +12.30% |
| Q4 2011 | 2011-12-31 | $3.4M | — | — | +47.44% |
| Q2 2012 · Sep 30 | 2011-09-30 | −$22,542 | −$1.1M | — | −0.26% |
| Q1 2012 · Jun 30 | 2011-06-30 | −$2.9M | −$2.4M | — | −37.61% |
| Q4 2011 | 2011-03-31 | $1.2M | — | — | +20.95% |
| Q2 2011 | 2010-09-30 | $1.0M | — | — | +14.29% |
| Q1 2011 | 2010-06-30 | −$525,310 | — | — | −7.49% |
Repligen free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from $40.2M to $93.9M, a compound annual growth rate of 18.51%. Repligen's latest reported quarter, Q2 2026, generated $27.4M in free cash flow, an increase of 27.54% year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Repligen source filings ↗